SCHEMBL17871066

SCHEMBL17871066

Nc1c(CC=O)cc(Br)nc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20075810 0.79 HTT (0.38) —
SCHEMBL28179935 0.75 — —
SCHEMBL3403322 0.68 ELANE (0.39) —
SCHEMBL25263196 0.67 ALDH1A1 (0.33) —
SCHEMBL1617849 0.66 HTR6 (0.32) —
SCHEMBL27749404 0.64 ALDH1A1 (0.32) —
SCHEMBL21261372 0.63 TDP1 (0.40) —
SCHEMBL31320527 0.63 NSD1 (0.33) —
SCHEMBL1977996 0.63 — —
SCHEMBL14698283 0.63 ALDH1A1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3237415-A1 TGF RECEPTOR ANTAGONISTS Bristol-Myers Squibb Company (US) 2017-11-01 — — EP disclosed
WO-2016106266-A1 TGFβ RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-06-30 — — WO disclosed
Send feedback